AbCellera Biologics (ABCL) Construction in Progress (2023 - 2025)
AbCellera Biologics' Construction in Progress was $3.5 million in Q4 2025, down 97.0% from $117.6 million a year earlier and down 97.6% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Construction in Progress (2023 - 2025) Analysis & Trends
From Q2 2023 onward, AbCellera Biologics has reported Construction in Progress for 11 quarters.
- In earlier years, Construction in Progress was $117.6 million in FY2024 (+758.4%) and $13.7 million in FY2023.
- The Q4 2025 figure marks the lowest quarterly Construction in Progress in data going back to Q2 2023.
- Compared with a year earlier, Construction in Progress was higher in six of the last seven quarters, with growth averaging 448.7%.
- Per Business Quant data, ABCL's Construction in Progress in the three quarters before Q4 2025 was $145.3 million (Q3 2025), $139.1 million (Q2 2025) and $126.2 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | - |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | - |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | AbCellera Biologics | 3.83 Bn | 3.29 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 145.30 Mn |
| Jun 30, 2025 | 139.10 Mn |
| Mar 31, 2025 | 126.20 Mn |
| Dec 31, 2024 | 117.60 Mn |
| Sep 30, 2024 | 108.40 Mn |
| Jun 30, 2024 | 13.00 Mn |
| Mar 31, 2024 | 15.20 Mn |
| Dec 31, 2023 | 13.70 Mn |
| Sep 30, 2023 | 13.20 Mn |
| Jun 30, 2023 | 10.50 Mn |
API Access
AbCellera Biologics Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();